Clinical Relevance of Neutralizing Antibodies in Botulinum Neurotoxin Type A
The precise definition of prevalence of neutralizing antibodies (NABs) affords cross-sectional testing of a cohort. But in most studies, only selected patients are tested. This leads to gross underestimation of NAB-prevalence, and the opinion that induction of NABs is a rare phenomenon in botulinum...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/81715 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Clinical Relevance of Neutralizing Antibodies in Botulinum Neurotoxin Type A
- Botulinum Neurotoxins
- Botulinum Neurotoxin Uses in Overactive Bladder
- The Non-Cosmetic Dermatological Use of Botulinum Neurotoxin
- Botulinum Toxin Complex: A Delivery Vehicle of Botulinum Neurotoxin Traveling Digestive Tract
- Label-Free Detection of Botulinum Neurotoxins Using a Surface Plasmon Resonance Biosensor
- Current Methods for Detecting the Presence of Botulinum Neurotoxins in Food and Other Biological Samples